25 Biology "Universidade Católica Portuguesa Porto" PhD positions at Karolinska Institutet
Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
single cell biology technologies as well as antibody engineering, high dimensional flow cytometry and functional assays to understand molecular mechanisms of various autoimmune diseases. The candidate will
-
for doctoral education . Skills and personal qualities We are seeking a highly motivated and scientifically driven individual to join our research team as a PhD candidate in cell biology. The ideal candidate
-
combination of advanced image processing, dedicated bioinformatic analysis, and experimental vascular biology. Based in a dynamic translational research environment of vascular surgery, biology, and imaging
-
biology, evolution and biodiversity, precision medicine and diagnostics, epidemiology and biology of infection. For more information, please see: Data-Driven Life Science (DDLS) - SciLifeLab The future
-
Forensic Medicine for medical students, as well as for Tumor biology courses for biomedicine students and Pathology courses for opticians. Do you want to contribute to improving human health? The laboratory
-
of four years of full-time doctoral education is required. The research group The Eroglu Lab is part of the Cell and Molecular Biology Department and is located in Biomedicum. The research group combines
-
diversification in response to acute infection. The project involves work with murine and human primary T cells, infections, advanced flow cytometry, cell sorting, molecular biology and analysis of single-cell RNA
-
of four years of full-time doctoral education is required. The Department of Microbiology, Tumor and Cell Biology (MTC) at Karolinska Institutet conducts research and teaching within immunology, infection
-
program has four strategic areas: cell and molecular biology, evolution and biodiversity, precision medicine and diagnostics, epidemiology and biology of infection. For more information, please see The
-
increasing the understanding of cancer biology at the proteome level. This enables the development of novel therapeutic strategies as well as the identification of biomarkers with predictive, prognostic and